Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | PETV |
---|---|---|
09:32 ET | 2000 | 0.8195 |
09:34 ET | 350 | 0.7605 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
PetVivo Holdings Inc | 13.2M | -0.9x | --- |
REMSleep Holdings Inc | 14.3M | -8.5x | --- |
Citrine Global Corp | 12.1M | -5.0x | --- |
Orgenesis Inc | 17.2M | -0.3x | --- |
Biomerica Inc | 12.0M | -1.8x | --- |
Agape ATP Corp | 19.5M | -8.8x | --- |
PetVivo Holdings, Inc. is a biomedical device company. The Company is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for animals. The Company’s lead product Spryng with OsteoCushion Technology, is a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The Company is primarily engaged in the business of commercializing and licensing products in the veterinary market to treat and/or manage afflictions of companion animals, such as dogs and horses. Its products are derived from biomaterials that simulate a body’s cellular tissue by virtue of their reliance upon natural protein and carbohydrate compositions, which incorporate such tissue building blocks as collagen, elastin, and proteoglycans such as heparin. The Company has a pipeline of therapeutic devices for both veterinary and human clinical applications.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $13.2M |
---|---|
Revenue (TTM) | $1.0M |
Shares Outstanding | 16.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.16 |
EPS | $-0.87 |
Book Value | $0.07 |
P/E Ratio | -0.9x |
Price/Sales (TTM) | 12.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,016.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.